NCT02840552View on ClinicalTrials.gov

The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

February 28, 2018

Study Completion Date

March 31, 2018

Conditions
Prostate Cancer
Interventions
DRUG

18F-Fluoromethylcholine (18F-FCH)

FCH PET/CT

Trial Locations (1)

H3T1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER

NCT02840552 - The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer | Biotech Hunter | Biotech Hunter